review Open AccessTop 1% cited

Drug-Induced Interstitial Lung Disease: A Systematic Review

Journal of Clinical Medicine · 2018 · Vol. 7(10) · pp. 356–356

Sarah Skeoch(Royal National Hospital for Rheumatic Diseases)Nicholas Weatherley(University of Sheffield)Andrew J. Swift(University of Sheffield)Alexander Oldroyd(University of Manchester)Christopher Johns(University of Sheffield)Conal Hayton(Manchester Academic Health Science Centre)Alessandro Giollo(University of Verona)Jim M. Wild(University of Sheffield)John C. Waterton(Manchester Academic Health Science Centre)Maya H Buch(University of Leeds)Kim Linton(Manchester Academic Health Science Centre)Ian N Bruce(Manchester Academic Health Science Centre)C.T. Leonard(Manchester Academic Health Science Centre)Stephen Bianchi(Sheffield Teaching Hospitals NHS Foundation Trust)Nazia Chaudhuri✉(Manchester Academic Health Science Centre)

View via DOI Full-text PDF

Abstract

Overall high-quality evidence in DIILD is lacking, and the current review will inform larger prospective studies to investigate the diagnosis and management of DIILD.

Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis Sarcoidosis and Beryllium Toxicity Research Drug-Induced Adverse ReactionsMedicineIntensive care medicineDiseaseInterstitial lung diseaseLung cancerSystematic reviewDrugInternal medicineProspective cohort studyMEDLINE